JP2022544057A5 - - Google Patents

Info

Publication number
JP2022544057A5
JP2022544057A5 JP2022506029A JP2022506029A JP2022544057A5 JP 2022544057 A5 JP2022544057 A5 JP 2022544057A5 JP 2022506029 A JP2022506029 A JP 2022506029A JP 2022506029 A JP2022506029 A JP 2022506029A JP 2022544057 A5 JP2022544057 A5 JP 2022544057A5
Authority
JP
Japan
Prior art keywords
pain
alkyl
aryl
heteroaryl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022506029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022544057A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/056915 external-priority patent/WO2021019373A1/en
Publication of JP2022544057A publication Critical patent/JP2022544057A/ja
Publication of JP2022544057A5 publication Critical patent/JP2022544057A5/ja
Pending legal-status Critical Current

Links

JP2022506029A 2019-07-31 2020-07-22 ニテニン類似体化合物ならびに慢性および急性疼痛の治療におけるそれらの使用 Pending JP2022544057A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PT11568519 2019-07-31
PT115685 2019-07-31
PCT/IB2020/056915 WO2021019373A1 (en) 2019-07-31 2020-07-22 Nitenin analogue compounds and their use in the treatment of chronic and acute pain

Publications (2)

Publication Number Publication Date
JP2022544057A JP2022544057A (ja) 2022-10-17
JP2022544057A5 true JP2022544057A5 (https=) 2024-02-20

Family

ID=72240450

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022506029A Pending JP2022544057A (ja) 2019-07-31 2020-07-22 ニテニン類似体化合物ならびに慢性および急性疼痛の治療におけるそれらの使用

Country Status (10)

Country Link
US (1) US12336977B2 (https=)
EP (1) EP4003984A1 (https=)
JP (1) JP2022544057A (https=)
CN (1) CN114616230A (https=)
AU (1) AU2020320115A1 (https=)
CA (1) CA3149175A1 (https=)
IL (1) IL290192A (https=)
MX (1) MX2022001186A (https=)
WO (1) WO2021019373A1 (https=)
ZA (1) ZA202201154B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4003984A1 (en) 2019-07-31 2022-06-01 Sea4Us - Biotecnologia e Recursos Marinhos, Lda. Nitenin analogue compounds and their use in the treatment of chronic and acute pain
CN116115739B (zh) * 2022-12-29 2024-01-09 天津市肿瘤医院(天津医科大学肿瘤医院) 胃动素及其受体激动剂的应用
WO2026013449A2 (en) * 2024-07-11 2026-01-15 Sea4Us - Biotecnologia E Recursos Marinhos, Sa Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7375136B2 (en) 2001-03-08 2008-05-20 Emory University pH-dependent NMDA receptor antagonists
GB0305149D0 (en) * 2003-03-07 2003-04-09 Cambridge Biotechnology Ltd Compounds for the treatment of pain
WO2007009462A2 (en) 2005-07-15 2007-01-25 Region Hovedstaden V/Glostrup Hospital Treatment of migraine and headaches
ES2345527B1 (es) 2008-10-08 2011-09-08 Hospital Clinic I Provincial De Barcelona Sustancias bloqueadoras de los canales kv 1.3 para el tratamiento de enfermedades asociadas a hiperplasia de la intima.
KR101939401B1 (ko) 2011-11-10 2019-01-16 가천대학교 산학협력단 단핵식세포계 세포의 age-알부민 합성 또는 분비 저해제를 유효성분으로 포함하는 허혈성 심장질환 예방 또는 치료용 조성물
CN106537149A (zh) * 2014-04-01 2017-03-22 宝洁公司 用于筛选色氨酸通道的方法
DK3126330T3 (en) 2014-04-04 2019-04-23 Pfizer BICYCLE-FUSED HETEROARYL OR ARYL COMPOUNDS AND USE THEREOF AS IRAC4 INHIBITORS
CN106146530A (zh) * 2015-04-14 2016-11-23 中国科学院生态环境研究中心 一种合成cephalosporolides E,F,H,I的新方法
EP4003984A1 (en) 2019-07-31 2022-06-01 Sea4Us - Biotecnologia e Recursos Marinhos, Lda. Nitenin analogue compounds and their use in the treatment of chronic and acute pain

Similar Documents

Publication Publication Date Title
JP2022544057A5 (https=)
US11040035B2 (en) 3-oxo-2,6-diphenyl-2,3-dihydropyridazine-4-carboxamides
IL273180B2 (en) Heteroaryl-modified beta-hydroxyethylamines for use in the treatment of hyperglycemia
RU2350605C2 (ru) Аналоги хиназолина в качестве ингибиторов рецепторных тирозинкиназ
EA023500B1 (ru) Соединения, композиции и способы их применения для коррекции уровня мочевой кислоты
RU2006131132A (ru) 1,3,5,-тризамещенные производные 4,5-дигидро-1н-пиразола, обладающие св1-антагонистической активностью
JP2022141692A5 (https=)
RU2016143333A (ru) Амидные производные и их фармацевтически приемлемые соли, способ их получения и медицинское применение
JP2021527126A5 (https=)
JP2010506854A5 (https=)
RU2007101653A (ru) Производные 1-азабицикло[3.3.1]нонанов
RU2010116708A (ru) Бициклическое производное гамма-аминокислоты
RU2008119842A (ru) Производные триазола в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы-1
JP2018538248A5 (https=)
WO2023129956A2 (en) Dimethyltryptamine analogues as nitric oxide delivery drugs
JP2022537140A5 (https=)
JP2020511536A5 (https=)
RU2012135698A (ru) Способ и композиция
RU2020119562A (ru) Хиназолиноновое соединение и его применение
JP2019529460A5 (https=)
JP2017503753A5 (https=)
RU2013136861A (ru) Новое производное индола или индазола или его соль
US10077236B2 (en) Azacyclic constrained analogs of FTY720
RU2005135439A (ru) Производные индена в качестве фармацевтических средств
RU2009128970A (ru) Производные изосорбидмононитрата для лечения кишечных заболеваний